Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

Abstract Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has compelled the implementation of novel thera...

Full description

Bibliographic Details
Main Authors: Soumya Gulab Katre, Alpana Jagdish Asnani, Kumar Pratyush, Nilima Gangadhar Sakharkar, Ashwini Gajanan Bhope, Kanchan Tekram Sawarkar, Vaibhav Santosh Nimbekar
Format: Article
Language:English
Published: SpringerOpen 2022-06-01
Series:Future Journal of Pharmaceutical Sciences
Subjects:
SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2)
MERS-CoV (Middle East respiratory syndrome coronavirus)
Mpro inhibitor (main protease inhibitor)
Virtual and in vitro screening
Online Access:https://doi.org/10.1186/s43094-022-00423-7

Internet

https://doi.org/10.1186/s43094-022-00423-7

Similar Items